Four-year results after brachytherapy for diffuse coronary in-stent restenosis: will coronary radiation therapy survive?

Cardiovascular Revascularization Medicine

Volumn 8, Issue 3, 2007, Pages 170-174

  Ruef, Johannes ^a   Hofmann, Manfred ^a   Störger, Hans ^a   Haase, Jürgen ^a  

^a Red Cross Hospital Cardiology Center   (Germany)

Author keywords

Coronary brachytherapy; Drug eluting stents; In stent restenosis; Reintervention

Indexed keywords

PHOSPHORUS 32; STRONTIUM 90; YTTRIUM 90;

AGED; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; STATISTICAL SIGNIFICANCE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BRACHYTHERAPY; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548221917     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2006.09.005     Document Type: Article

References (21)

1. Waksman R., Bhargava B., White L., Chan R., Mehran R., Lansky A., Mintz G., Satler L., Pichard A., Leon M., and Kent K. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 101 (2000) 1895-1898
2. 90Y beta-radiation versus placebo control for the treatment of in-stent restenosis. Am Heart J 149 4 (2005) 689-694
3. Rha S., Kuchulakanti P., Ajani A., Cheneau E., Pinnow E., Canos D., Torguson R., Pichard A., Satler L., Kent K., Ramee S., Teirstein P., Lindsay J., and Waksman R. Three-year follow-up after intravascular gamma-radiation for in-stent restenosis in saphenous vein grafts. Catheter Cardiovasc Interv 65 2 (2005) 257-262
4. Holmes D., Teirstein P., Satler L., Sketch M., O'Malley J., Popma J., Kuntz R., Fitzgerald P., Wang H., Caramanica E., Cohen S., and SISR Investigators. Sirolimus-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 295 11 (2006) 1264-1273
5. Stone G., Ellis S., O'Shaughnessy C., Martin S., Satler L., McGarry T., Turco M., Kereiakes D., Kelley L., Popma J., Russell M., and TAXUS V ISR Investigators. Paclitaxel-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 295 11 (2006) 1253-1263
6. 90Sr/Y brachytherapy system for intracoronary beta-radiation following PCI of diffuse in-stent restenosis. Cardiovasc Revasc Med 6 4 (2005) 140-146
7. King S., Williams D., Chougule P., Klein J., Waksman R., Hilstead R., Macdonald J., Anderberg K., and Crocker I. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the Beta Energy Restenosis Trial (BERT). Circulation 97 (1998) 2025-2030
8. Raizner A., Calfee R., Ali M., Bradshaw A., and Eno R. The Guidant coronary source wire system. In: Waksman R. (Ed). Vascular brachytherapy (1999), Futura Publishing Co., New York 505-519
9. Arjomand H., Turi Z., McCormick D., and Goldberg S. Percutaneous coronary intervention: historical perspectives, current status and future directions. Am Heart J 146 (2003) 787-796
10. Nguyen-Ho P., Kaluza G., Zymek P., and Raizner A. Intracoronary brachytherapy. Catheter Cardiovasc Interv 56 (2002) 281-1288
11. 90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation 106 9 (2002) 1090-1096
12. Waksman R., Raizner A., Yeung A., Lansky A., and Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 359 9306 (2002) 551-557
13. Grise M., Massullo V., Jani S., Popma J., Russo R., Schatz R., Guarneri E., Steuterman S., Cloutier D., Leon M., Tripuraneni P., and Teirstein P. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 105 23 (2002) 2737-2740
14. Waksman R., Ajani A., White R., Chan R., Bass B., Pichard A., Satler L., Kent K., Torguson R., Deible R., Pinnow E., and Lindsay J. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 109 3 (2004) 340-344
15. Haase J., Jung T., Störger H., Hofmann M., Reinemer H., Schwarz C., Schöpf J., and Schwarz F. Long-term outcome after implantation of bare metal stents fort he treatment of coronary artery disease. J Interv Cardiol 16 (2003) 469-473
16. Teirstein P., Massullo V., Jani S., Popma J., Russo R., Schatz R., Guarneri E., Steuterman S., Sirkin K., Cloutier D., Leon M., and Tripuraneni P. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 101 (2000) 360-365
17. Chu W., Torguson R., Pichard A., Satler L., Chan R., Porrazzo M., Kent K., Suddath W., and Waksman R. Drug-eluting stets versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation. J Invasive Cardiol 17 (2005) 659-662
18. Kaluza G., and Raizner A. Brachytherapy for restenosis after stenting for coronary artery disease: its role in the drug-eluting stent era. Curr Opin Cardiol 19 (2004) 601-607
19. Torguson R., Deible R., Smith K., Chu W., Kent K., Pichard A., Suddath W., Satler L., and Waksman R. Intravascular brachytherapy versus repeat drug-eluting stenting for the treatment of patients with drug-eluting stent restenosis. J Am Coll Cardiol 47 Suppl 2 (2006) B43 [Abstract]
20. Colombo A., and Corbett S. Drug-eluting stent thrombosis. J Am Coll Cardiol 48 (2006) 203-205
21. Joner M., Finn A., Farb A., Mont E., Kolodgie F., Ladich E., Kutys R., Skorija K., Gold H., and Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202